Professor Sir John Bell said he expects the Medicines and Healthcare products Regulatory Agency (MRHA) to sign off its approval of the jab ‘pretty shortly’.

Sir John, Oxford University’s regius professor of medicine, told BBC Radio 4’s Today programme: ‘They got data quite a long time ago but that was the first set of data. They receive multiple sets of data.

‘So we are getting to be about prime time now, I would expect some news pretty shortly. I doubt we’ll make Christmas now, but just after Christmas I would expect. I have no concerns whatsoever that the data looks better than ever.’

His comments came as former prime minister Tony Blair called for major policy shifts in the rollout of vaccines, concentrating on giving more people a single dose with greater flexibility in who receives a jab.

Approval of the Oxford vaccine would be a major boost to efforts to control Covid-19 because it is easier to distribute than the Pfizer/BioNTech jab currently being used in the UK.


Approval from regulators is expected shortly after Christmas


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine, with around 40 million available by the end of March.

Health Secretary Matt Hancock told a Downing Street press conference that the Oxford/AstraZeneca team has now submitted full data to the regulator for approval.

He said: ‘This is the next step towards a decision on the deployment of the vaccine which is already being manufactured, including here in the UK.’


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine


Mr Blair told Today ‘the reality is we are now in severe lockdown until vaccination’ and so it should be a priority to give as many people as possible some protection.

While ideally people should received the required two doses, the question is: ‘Does the first dose give you substantial immunity, and by that I mean over 50% effectiveness?

‘If it does, there is a very strong case for not, as it were, holding back doses of the vaccine.’


A volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University


For example ‘if, in January, AstraZeneca is delivering you 10 or 20 million doses of the vaccine, you vaccinate 10 or 20 million people’.

Mr Blair went on: ‘You should get more vaccine coming on stream by the time you are ready for the second dose and that first dose can give you substantial immunity.’

The former premier also criticised the ‘somewhat inflexible “by age” structure’ used to determine who receives the jab.


A vial of coronavirus vaccine developed by AstraZeneca and Oxford University


Experts at the Joint Committee on Vaccination and Immunisation have drawn up a priority list based on clinical need.

But Mr Blair, who does not have a medical background, said ‘there is a strong case for saying you have got to focus also on the people spreading the disease, not simply the most vulnerable’.

Communities Secretary Robert Jenrick told Today that the Government is focusing on getting as many people as possible to receive the first dose of the Pfizer vaccine.

He said: ‘At the moment the priority is just to ensure that as many people as possible get the first shot of the vaccine.

‘Remember, the second shot has to be done, depending on what the vaccine is, 21 or 28 days later and so we still haven’t reached that point with the first people who were vaccinated.’

Asked whether the Government would consider dropping the second shot, Mr Jenrick said: ‘The strategy will always be kept under review but the priority today is to ensure that as many people as possible are given the first shot of the vaccine; that is what is happening.’